View of Recent targeted therapies addition to standard chemotherapy regimen in mismatch repair deficient (Dmmr) primary advanced or recurrent endometrial cancer, to what significance? A network meta-analysis

Return to Article Details Recent targeted therapies addition to standard chemotherapy regimen in mismatch repair deficient (Dmmr) primary advanced or recurrent endometrial cancer, to what significance? A network meta-analysis Download Download PDF

Cited by

	All	Since 2021
Citations	3363	3146
h-index	22	22
i10-index	76	76

0

1800

900

450

1350

20152016201720182019202020212022202320242025202620 18 21 30 42 55 103 298 354 572 1741 51